In colon cancer, a mechanism by which RAS accelerates tumorigenesis is via AKT‐mediated modulation of β‐catenin's degradation, and increasing levels of cytosolic β‐catenin and canonical WNT/β‐catenin pathway activation. This evidence concerns the gene AKT1 and colonic neoplasm.